Literature DB >> 23618391

Morbidities of lung cancer surgery in obese patients.

Binod Dhakal1, Daniel Eastwood, Sunitha Sukumaran, George Hassler, William Tisol, Mario Gasparri, Nicholas Choong, Rafael Santana-Davila.   

Abstract

BACKGROUND: Obesity is a risk factor for increased perioperative morbidity and mortality in surgical patients. There have been limited studies to correlate the morbidity of lung cancer resection with obesity.
METHODS: We performed a retrospective study of patients who underwent surgical resection for lung cancer at the Medical College of Wisconsin, Milwaukee, from 2006 to 2010. Data on patient demographics, weight, pathological findings, and hospital course were abstracted after appropriate institutional review board approval. Perioperative morbidity was defined as atrial fibrillation, heart failure, respiratory failure, pulmonary embolism, or any medical complications arising within 30 days after surgery. The Fisher exact test was used to test the association between body mass index (BMI) and perioperative morbidities.
RESULTS: Between 2006 and 2010, 320 lung resections were performed for lung cancer. The median age was 67 (interquartile range, 59-75) years, and 185 (57.8%) were females. A total of 121 (37.8%) of patients had a BMI lower than 25, and 199 (62.18%) patients had a BMI of 25 or higher. The 30-day mortality rate was 1.8% (n = 6) in the whole group; only 2 of these patients had a BMI of 25 or higher. Perioperative morbidity occurred in 28 (23.14%) of patients with a normal BMI and in 47 (23.61%) of patients with a BMI of 25 or higher (P = .54). Specific morbidities encountered by patients with normal versus BMI of 25 or higher were as follows: atrial fibrillation, 11 (9.09%) versus 24 (12.06%) (P = .46); pulmonary embolism, 1 (0.83%) versus 3 (1.51%) (P = 1.0); congestive heart failure, 2 (1.65%) versus 2 (1.01%) (P = .63); renal failure, 4 (3.3%) versus 2 (1.0%) (P = .29); respiratory failure, 12 (9.92%) versus 17 (8.54%) (P = .69); and acute respiratory distress syndrome, 2 (1.65%) versus 1 (0.50%) (P = .55). The median hospital stay was 5 days in the lower BMI group and 4 days in the BMI of 25 or higher group (P = .52).
CONCLUSIONS: Overweight and normal weight patients do not differ significantly in rates of perioperative morbidities, 30-day mortality, and length of stay. Our study indicates that potential curative surgical resections can be offered to even significantly overweight patients. Published by Mosby, Inc.

Entities:  

Keywords:  10; BMI; CI; COPD; FEV(1); OR; body mass index; chronic obstructive pulmonary disease; confidence interval; forced expiratory volume in 1 second; odds ratio

Mesh:

Year:  2013        PMID: 23618391      PMCID: PMC4986510          DOI: 10.1016/j.jtcvs.2013.02.083

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  20 in total

1.  Resection rates and postoperative mortality in 7,899 patients with lung cancer.

Authors:  R A Damhuis; P R Schütte
Journal:  Eur Respir J       Date:  1996-01       Impact factor: 16.671

Review 2.  Body mass index and outcomes from pancreatic resection: a review and meta-analysis.

Authors:  Andrew M Ramsey; Robert C Martin
Journal:  J Gastrointest Surg       Date:  2011-04-12       Impact factor: 3.452

3.  Operative mortality and five year survival rates in patients with bronchogenic carcinoma.

Authors:  W Weiss
Journal:  Am J Surg       Date:  1974-12       Impact factor: 2.565

Review 4.  Medical hazards of obesity.

Authors:  F X Pi-Sunyer
Journal:  Ann Intern Med       Date:  1993-10-01       Impact factor: 25.391

5.  Hospital mortality and long-term survival in relation to preoperative function in elderly patients with bronchogenic carcinoma.

Authors:  H Berggren; R Ekroth; R Malmberg; J Naucler; G William-Olsson
Journal:  Ann Thorac Surg       Date:  1984-12       Impact factor: 4.330

6.  Health services use and health care costs of obese and nonobese individuals.

Authors:  Marsha A Raebel; Daniel C Malone; Douglas A Conner; Stanley Xu; Julie A Porter; Frances A Lanty
Journal:  Arch Intern Med       Date:  2004-10-25

7.  Body mass index and pancreatic cancer risk: A meta-analysis of prospective studies.

Authors:  Susanna C Larsson; Nicola Orsini; Alicja Wolk
Journal:  Int J Cancer       Date:  2007-05-01       Impact factor: 7.396

8.  The impact of preoperative body mass index on respiratory complications after pneumonectomy for non-small-cell lung cancer. Results from a series of 154 consecutive standard pneumonectomies.

Authors:  Francesco Petrella; Davide Radice; Alessandro Borri; Domenico Galetta; Roberto Gasparri; Piergiorgio Solli; Giulia Veronesi; Lorenzo Spaggiari
Journal:  Eur J Cardiothorac Surg       Date:  2010-10-16       Impact factor: 4.191

Review 9.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.

Authors:  Andrew G Renehan; Margaret Tyson; Matthias Egger; Richard F Heller; Marcel Zwahlen
Journal:  Lancet       Date:  2008-02-16       Impact factor: 79.321

10.  Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial.

Authors:  Mark S Allen; Gail E Darling; Taine T V Pechet; John D Mitchell; James E Herndon; Rodney J Landreneau; Richard I Inculet; David R Jones; Bryan F Meyers; David H Harpole; Joe B Putnam; Valerie W Rusch
Journal:  Ann Thorac Surg       Date:  2006-03       Impact factor: 4.330

View more
  10 in total

1.  A survival analysis using physique-adjusted tumor size of non-small cell lung cancer.

Authors:  Naoki Ozeki; Takayuki Fukui; Koji Kawaguchi; Shota Nakamura; Shuhei Hakiri; Taketo Kato; Akihiro Hirakawa; Kohei Yokoi
Journal:  Int J Clin Oncol       Date:  2017-11-29       Impact factor: 3.402

2.  Association of body mass index and outcomes after major lung resection.

Authors:  Mark K Ferguson; Hae Kyung Im; Sydeaka Watson; Elizabeth Johnson; Christopher H Wigfield; Wickii T Vigneswaran
Journal:  Eur J Cardiothorac Surg       Date:  2014-02-05       Impact factor: 4.191

3.  Operative Risk for Major Lung Resection Increases at Extremes of Body Mass Index.

Authors:  Trevor Williams; Brian C Gulack; Sunghee Kim; Felix G Fernandez; Mark K Ferguson
Journal:  Ann Thorac Surg       Date:  2016-07-29       Impact factor: 4.330

4.  Evaluation of emphysema using three-dimensional computed tomography: association with postoperative complications in lung cancer patients.

Authors:  Kenichi Kawakami; Shingo Iwano; Naozumi Hashimoto; Yoshinori Hasegawa; Shinji Naganawa
Journal:  Nagoya J Med Sci       Date:  2015-02       Impact factor: 1.131

5.  Low Body Mass Index Is an Independent Predictive Factor after Surgical Resection in Patients with Non-Small Cell Lung Cancer

Authors:  Masaki Tomita; Takanori Ayabe; Kunihide Nakamura
Journal:  Asian Pac J Cancer Prev       Date:  2017-12-29

Review 6.  Lung Cancer and Pulmonary Embolism: What Is the Relationship? A Review.

Authors:  Yupeng Li; Yu Shang; Wenwen Wang; Shangwei Ning; Hong Chen
Journal:  J Cancer       Date:  2018-08-06       Impact factor: 4.207

7.  The Role of Obesity in Early and Long-Term Outcomes after Surgical Excision of Lung Oligometastases from Colorectal Cancer.

Authors:  Francesco Londero; Orlando Parise; William Grossi; Angelo Morelli; Gianluca Masullo; Michele Bartoletti; Cecilia Tetta; Ugolino Livi; Jos G Maessen; Sandro Gelsomino
Journal:  J Clin Med       Date:  2020-11-05       Impact factor: 4.241

8.  Carinal resection and reconstruction with complete pulmonary parenchyma preservation: a single-institution analysis of 36 cases.

Authors:  Liang Chen; Zhexin Wang; Heng Zhao; Giulio Maurizi; Takuro Miyazaki; Ryuichi Waseda; Feng Yao
Journal:  Transl Lung Cancer Res       Date:  2021-12

9.  "Obesity Paradox" in Acute Respiratory Distress Syndrome: Asystematic Review and Meta-Analysis.

Authors:  Guo Zhi; Wang Xin; Wang Ying; Xing Guohong; Liu Shuying
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

10.  Association of body mass index and outcomes following lobectomy for non-small-cell lung cancer.

Authors:  Cui Wang; Min Guo; Nan Zhang; Gongchao Wang
Journal:  World J Surg Oncol       Date:  2018-05-11       Impact factor: 2.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.